Disease/Infection News

RSS

Article describes feasibility and costs of active tuberculosis case finding project in Cape Town

A research article by Katharina Kranzer from the London School of Hygiene & Tropical Medicine and colleagues describe the feasibility and costs of an active tuberculosis case finding project in Cape Town, South Africa.

8 Aug 2012

GeneXpert TB test maker Cepheid signs deals with PEPFAR, USAID, others to provide lower-cost kits

Diagnostics company Cepheid on Monday signed deals with PEPFAR, USAID, UNITAID, and the Bill & Melinda Gates Foundation to immediately reduce the price of its Xpert MTB/RIF test kit for its GeneXpert tuberculosis (TB) diagnostic system in 145 countries, Reuters reports.

8 Aug 2012

Neutral-pressure IV connector eliminates catheter-related bloodstream infections in cancer patients

A neutral-pressure IV needleless connector was associated with complete elimination of catheter-related bloodstream infections (CRBSI) in a successful device trial at a large cancer center in the six-month period following implementation of the device.

8 Aug 2012

Researchers help quell parents' worry about why infants seem to get sick so often

Researchers at the University of Michigan Health System are helping to quell parents' worry about why infants seem to get sick so often.

8 Aug 2012

Review explores whether HPV vaccination of young men is warranted and cost effective

Vaccination against human papilloma virus (HPV) is recommended for young women to protect them from HPV infection and cervical cancer. Male HPV immunization is increasingly a topic of debate in the medical community. A timely review of the literature published in Viral Immunology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers, explores whether HPV vaccination of young men is warranted and cost effective.

8 Aug 2012

UMass Medical, Serum Institute of India partner on anti-rabies monoclonal antibody pivotal trial

A pivotal clinical trial for an anti-rabies human monoclonal antibody (RMAb) being developed through a collaborative partnership between MassBiologics of the University of Massachusetts Medical School and the Serum Institute of India, Ltd., is starting to enroll patients.

8 Aug 2012

Communal violence in India forces up to 400,000 into overcrowded camps without sufficient food, water, medicine

"Hundreds of thousands of people sheltering in squalid, overcrowded camps in India's northeast desperately need food, water and medicines after fleeing some of the worst communal violence in a decade, officials and aid workers said on Monday," AlertNet reports.

8 Aug 2012

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

BioDiem recently signed a collaborative agreement with The Royal Melbourne Institute of Technology (RMIT) for the development of non-influenza vaccines using BioDiem’s proprietary live attenuated influenza virus (LAIV) technology.

7 Aug 2012

Cannabis-based medications prove effective in relieving pain

Cannabis-based medications have been proved to relieve pain. This is the conclusion drawn by Franjo Grotenhermen and Kirsten Müller-Vahl in issue 29-30 of Deutsches Ärzteblatt International.

7 Aug 2012

Advances in HIV/AIDS therapy and the International AIDS Conference: an interview with Professor Sharon Lewin

The anti-HIV drugs, also known as anti-retroviral therapy, came about in the mid ‘90’s. These involved using at least 3 different drugs together.

7 Aug 2012

IPS reports on efforts to prevent mother-to-child HIV transmission at public hospital in Cameroon

"For nearly two years, not a single child with HIV has been born at the public hospital in the Cite-Verte district of Yaounde, the capital of Cameroon," Inter Press Service reports, adding, "Emilien Fouda, the hospital's director, says this proud record is the result of combined effort by his staff and community support groups."

7 Aug 2012

Commercial cattle vaccine can effectively reduce levels of E. coli by more than 50%

A commercial vaccine for cattle can effectively reduce levels of E. coli by more than 50 percent, a Kansas State University study has found. The vaccine is also effective using two doses instead of the recommended three doses, which can help cut costs for the beef industry.

7 Aug 2012

Clinton expresses concern over HIV in Uganda, stops in Malawi on 11-day African tour

U.S. Secretary of State Hillary Clinton "expressed concern" over Uganda's increasing number of HIV infections on a visit to the country last week, part of an 11-day trip to eight African nations, Uganda's New Vision reports (Mukasa, 8/4).

6 Aug 2012

Uganda Ebola virus outbreak under control, WHO says

The Ebola virus outbreak that began last month in Uganda is under control, with health agencies having isolated the 176 people who had even slight contact with people who have contracted the virus, Joaquim Saweka, the WHO representative in Uganda, told reporters.

6 Aug 2012

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has commenced commercial operations in India, starting with the launch of a comprehensive portfolio of 18 antiretroviral (ARV) products for the treatment of HIV/AIDS.

6 Aug 2012

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

A significant discovery in the development of next-generation antibiotics has been made by Scottish biotechnology company Aquapharm.

6 Aug 2012

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Genocea Biosciences announced today the presentation of new data supporting its novel approach to developing a first-in-class, protein subunit therapeutic vaccine for Herpes Simplex Virus type 2 (HSV-2).

6 Aug 2012

Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events

Luminex Corporation announced today that Public Health Wales is using Luminex's CE marked xTAG Gastrointestinal Pathogen Panel (GPP) for outbreak investigation activities during Olympic and Paralympic training and events taking place in Wales. Results of a substantial diagnostic validation of the GPP test conducted by The Public Health Wales Microbiology laboratory team at the University Hospital of Wales, Cardiff, are anticipated to be published in a peer reviewed journal

From Luminex 6 Aug 2012

Drug molecules designed for influenza may be adapted to treat other viruses

St. Jude Children's Research Hospital study shows how compounds blocking an enzyme universal to all influenza viruses may allow development of new antiviral drugs that also avoid the problem of drug resistance

3 Aug 2012

Science magazine recaps issues discussed at AIDS 2012

Science looks back at the XIX International AIDS Conference (AIDS 2012), which ended last week in Washington, D.C., writing, "The battle against HIV is having more success than ever. ... But several presentations made clear that a gulf separates aspirations from reality when it comes to 'ending AIDS,' which [Secretary of State Hillary] Clinton and many other prominent speakers at the conference emphasized was now possible."

3 Aug 2012

Disease/Infection News

Article describes feasibility and costs of active tuberculosis case finding project in Cape Town

GeneXpert TB test maker Cepheid signs deals with PEPFAR, USAID, others to provide lower-cost kits

Neutral-pressure IV connector eliminates catheter-related bloodstream infections in cancer patients

Researchers help quell parents' worry about why infants seem to get sick so often

Review explores whether HPV vaccination of young men is warranted and cost effective

UMass Medical, Serum Institute of India partner on anti-rabies monoclonal antibody pivotal trial

Communal violence in India forces up to 400,000 into overcrowded camps without sufficient food, water, medicine

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

Cannabis-based medications prove effective in relieving pain

Advances in HIV/AIDS therapy and the International AIDS Conference: an interview with Professor Sharon Lewin

IPS reports on efforts to prevent mother-to-child HIV transmission at public hospital in Cameroon

Commercial cattle vaccine can effectively reduce levels of E. coli by more than 50%

Clinton expresses concern over HIV in Uganda, stops in Malawi on 11-day African tour

Uganda Ebola virus outbreak under control, WHO says

Mylan launches 18 antiretroviral products in India to treat HIV/AIDS

Aquapharm discovers new antibiotic compound against multi-drug resistant bacteria

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events

Drug molecules designed for influenza may be adapted to treat other viruses

Science magazine recaps issues discussed at AIDS 2012

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News